David M. Novick

2.1k total citations
53 papers, 1.6k citations indexed

About

David M. Novick is a scholar working on Epidemiology, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David M. Novick has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 19 papers in Hepatology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David M. Novick's work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (11 papers) and Opioid Use Disorder Treatment (10 papers). David M. Novick is often cited by papers focused on Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (11 papers) and Opioid Use Disorder Treatment (10 papers). David M. Novick collaborates with scholars based in United States, United Kingdom and Italy. David M. Novick's co-authors include Mary Jeanne Kreek, Howard C. Thomas, Anna S. Lok, Alvin M. Gelb, Herman Joseph, Stanley R. Yancovitz, T S Croxson, M J Kreek, Peter Karayiannis and Edwin A. Salsitz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Gastroenterology.

In The Last Decade

David M. Novick

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Novick United States 24 909 478 399 203 180 53 1.6k
Markus Backmund Germany 24 1.7k 1.9× 1.5k 3.2× 332 0.8× 271 1.3× 132 0.7× 53 2.2k
Rajesh Varma United Kingdom 24 451 0.5× 337 0.7× 454 1.1× 76 0.4× 160 0.9× 85 2.2k
W. Jeffrey Fessel United States 23 658 0.7× 304 0.6× 60 0.2× 438 2.2× 133 0.7× 55 1.9k
David Zucman France 18 369 0.4× 205 0.4× 49 0.1× 589 2.9× 101 0.6× 71 1.3k
Paolo Mezzelani Italy 18 506 0.6× 334 0.7× 123 0.3× 64 0.3× 36 0.2× 49 907
Daniel Fuster Spain 19 658 0.7× 451 0.9× 55 0.1× 199 1.0× 32 0.2× 66 1.0k
Margaret MacDonald Australia 15 835 0.9× 419 0.9× 304 0.8× 249 1.2× 10 0.1× 32 1.1k
Ellen Tedaldi United States 26 865 1.0× 428 0.9× 149 0.4× 1.2k 5.9× 101 0.6× 52 2.2k
Ari Illeperuma United States 7 857 0.9× 588 1.2× 353 0.9× 133 0.7× 16 0.1× 13 1.2k
Ana Milinkovic Spain 25 818 0.9× 664 1.4× 121 0.3× 1.4k 6.7× 57 0.3× 70 2.3k

Countries citing papers authored by David M. Novick

Since Specialization
Citations

This map shows the geographic impact of David M. Novick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Novick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Novick more than expected).

Fields of papers citing papers by David M. Novick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Novick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Novick. The network helps show where David M. Novick may publish in the future.

Co-authorship network of co-authors of David M. Novick

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Novick. A scholar is included among the top collaborators of David M. Novick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Novick. David M. Novick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novick, David M.. (2017). A Gastroenterologist’s Guide to Gut Health. Rowman & Littlefield Publishers eBooks. 1 indexed citations
2.
Neff, Guy, Michael Jones, Mark Jonas, et al.. (2013). Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 47(2). 188–192. 22 indexed citations
3.
Neff, Guy, Michael Jones, Taylor Broda, et al.. (2011). Durability of Rifaximin Response in Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 46(2). 168–171. 23 indexed citations
4.
Novick, David M., et al.. (2011). Malignant Polyp in a Colonic Diverticulum: a Rare Cause of Diverticular Hemorrhage. Journal of Gastrointestinal Cancer. 43(S1). 104–107. 1 indexed citations
5.
Neff, Guy, Nyingi Kemmer, Tiffany E. Kaiser, et al.. (2006). Analysis of Hospitalizations Comparing Rifaximin Versus Lactulose in the Management of Hepatic Encephalopathy. Transplantation Proceedings. 38(10). 3552–3555. 49 indexed citations
6.
Lloyd‐Sherlock, Peter & David M. Novick. (2001). “Voluntary” User Fees in Buenos Aires Hospitals: Innovation or Imposition?. International Journal of Health Services. 31(4). 709–728. 7 indexed citations
7.
Novick, David M., et al.. (1994). Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians’ offices (medical maintenance). Journal of General Internal Medicine. 9(3). 127–130. 55 indexed citations
8.
Novick, David M. & Herman Joseph. (1991). Medical maintenance: The treatment of chronic opiate dependence in general medical practice. Journal of Substance Abuse Treatment. 8(4). 233–239. 37 indexed citations
9.
Novick, David M., et al.. (1991). In vivo and In vitro Studies of Opiates and Cellular Immunity in Narcotic Addicts. Advances in experimental medicine and biology. 288. 159–170. 18 indexed citations
10.
Levine, Carol & David M. Novick. (1990). Expanding the Role of Physicians in Drug Abuse Treatment: Problems, Perspectives. The Journal of Clinical Ethics. 1(2). 152–156. 4 indexed citations
11.
Kreek, M J, et al.. (1990). Contrasting Prevalence of Delta Hepatitis Markers in Parenteral Drug Abusers with and without AIDS. The Journal of Infectious Diseases. 162(2). 538–541. 24 indexed citations
12.
Farci, Patrizia, David M. Novick, Maria Eliana Lai, et al.. (1989). T lymphocyte subsets and viral infections in sardinian parenteral drug abusers: Relationship to HIV infection. Journal of Medical Virology. 27(2). 81–86. 3 indexed citations
13.
Farci, Patrizia, et al.. (1988). INTRODUCTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION AMONG PARENTERAL DRUG ABUSERS IN SARDINIA: A SEROEPIDEMIOLOGIC STUDY. American Journal of Epidemiology. 127(6). 1312–1314. 5 indexed citations
14.
Novick, David M., Don C. Des Jarlais, Mary Jeanne Kreek, et al.. (1988). Specificity of Antibody Tests for Human Immunodeficiency Virus in Alcohol and Parenteral Drug Abusers with Chronic Liver Disease. Alcoholism Clinical and Experimental Research. 12(5). 687–690. 10 indexed citations
15.
Novick, David M.. (1988). Methadone maintenance patients in general medical practice. A preliminary report. JAMA. 259(22). 3299–3302. 16 indexed citations
16.
Novick, David M., Patrizia Farci, T S Croxson, et al.. (1988). Hepatitis D Virus and Human Immunodeficiency Virus Antibodies in Parenteral Drug Abusers Who Are Hepatitis B Surface Antigen Positive. The Journal of Infectious Diseases. 158(4). 795–803. 49 indexed citations
17.
Novick, David M., et al.. (1986). Chronic Liver Disease in Abusers of Alcohol and Parenteral Drugs: A Report of 204 Consecutive Biopsy‐Proven Cases. Alcoholism Clinical and Experimental Research. 10(5). 500–505. 20 indexed citations
18.
Karayiannis, Peter, David M. Novick, Anna S. Lok, et al.. (1985). Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen.. BMJ. 290(6485). 1853–1855. 58 indexed citations
19.
Novick, David M., Alvin M. Gelb, R. Stenger, et al.. (1985). Hepatic cirrhosis in young adults: association with adolescent onset of alcohol and parenteral heroin abuse.. Gut. 26(1). 8–13. 26 indexed citations
20.
Novick, David M., Alvin M. Gelb, R. Stenger, et al.. (1981). Hepatitis B serologic studies in narcotic users with chronic liver disease.. PubMed. 75(2). 111–5. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Backmund Breakdown of academic impact, for papers by Rajesh Varma Breakdown of academic impact, for papers by W. Jeffrey Fessel Breakdown of academic impact, for papers by David Zucman Breakdown of academic impact, for papers by Paolo Mezzelani Breakdown of academic impact, for papers by Daniel Fuster Breakdown of academic impact, for papers by Margaret MacDonald Breakdown of academic impact, for papers by Ellen Tedaldi Breakdown of academic impact, for papers by Ari Illeperuma Breakdown of academic impact, for papers by Ana Milinkovic
Rankless by CCL
2026